Cargando…

Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant

BACKGROUND. Lung transplant patients are vulnerable to various forms of allograft injury, whether from acute rejection (AR) (encompassing acute cellular rejection [ACR] and antibody-mediated rejection [AMR]), chronic lung allograft dysfunction (CLAD), or infection (INFXN). Previous research indicate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenheck, Justin P., Ross, David J., Botros, Mena, Wong, Alexander, Sternberg, Jonathan, Chen, Yen-An, Liang, Nathan, Baer, Amy, Ahmed, Ebad, Swenerton, Ryan, Zimmermann, Bernhard G., Fehringer, Gordon, Demko, Zachary P., Olymbios, Michael, Billings, Paul R., Keller, Brian C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Lung Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963832/ https://www.ncbi.nlm.nih.gov/pubmed/35372675 http://dx.doi.org/10.1097/TXD.0000000000001317

Ejemplares similares

Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and Infection
por: Rosenheck, J.P., et al.
Publicado: (2022)

A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation
por: Kim, Paul J., et al.
Publicado: (2022)

Effect of β-Nicotinamide Adenine Dinucleotide on Acute Allograft Rejection After Rat Lung Transplantation
por: Ehrsam, Jonas P., et al.
Publicado: (2023)

Selective Recruitment of Large Lower Lobe Atelectasis on Donor Back Table in Rejected Donor Lungs
por: Okamoto, Toshihiro, et al.
Publicado: (2019)

Plasma Donor-derived Cell-free DNA Levels Are Increased During Acute Cellular Rejection After Lung Transplant: Pilot Data
por: Sayah, David, et al.
Publicado: (2020)

Pulmonary Allograft Versus Host Disease
por: Dai, David W., et al.
Publicado: (2017)

Relative Change in Donor-Derived Cell-free DNA is Superior to Absolute Values for Diagnosis of Acute Lung Allograft Dysfunction
por: Trindade, Anil J., et al.
Publicado: (2023)

Unilateral Chronic Lung Allograft Dysfunction Assessed by Biphasic Computed Tomographic Volumetry in Bilateral Living-donor Lobar Lung Transplantation
por: Saito, Masao, et al.
Publicado: (2018)

Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection
por: Hostetler, Haley P., et al.
Publicado: (2021)

The Role of Galectins in Chronic Lung Allograft Dysfunction
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation
por: Naik, Chetan, et al.
Publicado: (2018)

Cytomegalovirus Immunity Assays Predict Viremia but not Replication Within the Lung Allograft
por: Li, Jenny, et al.
Publicado: (2023)

Risk of Lung Allograft Dysfunction Associated With Aspergillus Infection
por: Le Pavec, Jérôme, et al.
Publicado: (2021)

Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction
por: Kotecha, Sakhee, et al.
Publicado: (2021)

Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction
por: Bennett, David, et al.
Publicado: (2022)

Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients
por: Altuğ, Yücel, et al.
Publicado: (2019)

Assessment of Carfilzomib Treatment Response in Lung Transplant Recipients With Antibody-mediated Rejection
por: Pham, Christine, et al.
Publicado: (2021)

Surviving White-out: How to Manage Severe Noninfectious Acute Lung Allograft Dysfunction of Unknown Etiology
por: Trindade, Anil J., et al.
Publicado: (2022)

Viral Respiratory Tract Infection During the First Postoperative Year Is a Risk Factor for Chronic Rejection After Lung Transplantation
por: Magnusson, Jesper, et al.
Publicado: (2018)

Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than dendritic cells
por: Ward, C, et al.
Publicado: (2009)

Assessment of dd-cfDNA Levels in Clinically Stable Lung Allograft Recipients Beyond the Initial 2 y Posttransplant
por: Trindade, Anil J., et al.
Publicado: (2022)

Donor Leukocyte Trafficking and Damage-associated Molecular Pattern Expression During Ex Vivo Lung Perfusion
por: Davis, Robert P., et al.
Publicado: (2020)

Determining Clinical Thresholds for Donor HLA Eplet Compatibility to Predict Best Outcomes Following Lung Transplantation
por: Hiho, Steven J., et al.
Publicado: (2022)

A Mixed-chimerism Protocol Utilizing Thymoglobulin and Belatacept Did Not Induce Lung Allograft Tolerance, Despite Previous Success in Renal Allotransplantation
por: Sommer, Wiebke, et al.
Publicado: (2021)

Intravascular donor monocytes play a central role in lung transplant ischaemia-reperfusion injury
por: Tatham, Kate Colette, et al.
Publicado: (2018)

DQA1 Eplet Mismatch Load As an Independent Risk Factor of CLAD After Lung Transplantation
por: González-López, Elena, et al.
Publicado: (2023)

Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation
por: Halloran, Philip F., et al.
Publicado: (2022)

Lung Transplant Candidates With Pretransplant Gastroesophageal Reflux and Antibodies to Lung Self-antigens Have Shorter CLAD-free Survival After Transplant
por: Razia, Deepika, et al.
Publicado: (2022)

CLINICAL OUTCOMES IN LUNG TRANSPLANT RECIPIENTS WITH SARS-COV-2
por: BOTROS, MENA, et al.
Publicado: (2021)

Recurrent Mild Acute Rejections and Donor-specific Antibodies as Risk Factors for Cardiac Allograft Vasculopathy in a National Pediatric Heart Transplant Cohort
por: Kaskinen, Anu K., et al.
Publicado: (2023)

Activin Biology After Lung Transplantation
por: Westall, Glen P., et al.
Publicado: (2017)

A Prospective Observational Study of Hypogammaglobulinemia in the First Year After Lung Transplantation
por: Petrov, Andrej A., et al.
Publicado: (2018)

Lung Transplantation for Pulmonary Fibrosis Associated With Hermansky-Pudlak Syndrome. A Single-center Experience
por: Benvenuto, Luke, et al.
Publicado: (2022)

Decreased Lymphocytic Bronchitis Severity in the Era of Azithromycin Prophylaxis
por: Santos, Jesse, et al.
Publicado: (2023)

One Year Into the Pandemic: Evolving COVID-19 Outcomes in Lung Transplant Recipients, a Single-center Experience
por: Laothamatas, Kemarut, et al.
Publicado: (2022)

The SHELTER Trial of Transplanting Hepatitis C Virus–Infected Lungs Into Uninfected Recipients
por: Reese, Peter P., et al.
Publicado: (2023)

The Role of Complement Split-products as Biomarkers for Acute Antibody-mediated Rejection of Kidney Allografts
por: Abu Jawdeh, Bassam G., et al.
Publicado: (2022)

Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes
por: Cohen, Jordana B., et al.
Publicado: (2017)

Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection
por: Bunnapradist, Suphamai, et al.
Publicado: (2021)

Primary mesenchymal stem cells in human transplanted lungs are CD90/CD105 perivascularly located tissue-resident cells
por: Rolandsson, Sara, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_okiubh7je2q0sjtelc5ec62rm3